CASH FLOW
Alivus Life Sciences Ltd.
BSE
Jul 23, 11:35
1039.00
-8.40 ( -0.80%)
Volume
914
Prev. Close
1047.40
Open Price
1047.00
Bid Price(Qty.)
1036.30 (3)
Offer Pr.(Qty.)
1038.35 (11)
NSE
Jul 23, 11:24
1037.90
-11.00 ( -1.05%)
Volume
19129
Prev. Close
1048.90
Open Price
1042.60
Bid Price(Qty.)
1037.10 (17)
Offer Pr.(Qty.)
1037.90 (1)
You can view the
Cash Flow
for the last 5 years.
ISIN No
|
INE03Q201024
|
Market Cap. ( ₹ in Cr. )
|
12727.68
|
P/BV
|
5.01
|
Book Value ( ₹ )
|
207.01
|
BSE Code
|
543322
|
52 Week High/Low ( ₹ )
|
1335/819
|
FV/ML
|
2/1
|
P/E(X)
|
26.21
|
NSE Code
|
ALIVUSEQ
|
Book Closure
|
17/10/2023
|
EPS ( ₹ )
|
39.60
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | 654.13 | 631.29 | 628.61 | 564.93 | 470.94 |
| | | | | |
Net CashFlow From Operating Activities | 391.52 | 413.52 | 313.40 | 597.59 | 388.11 |
Net Cash Used In Investing Activities | -615.65 | -116.48 | -154.15 | -122.23 | -68.73 |
Net Cash Used From Financing Activities | -6.23 | -279.44 | -387.59 | -78.80 | -213.78 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | -230.35 | 17.59 | -228.33 | 396.56 | 105.60 |
Cash And Cash Equivalents Begin of Year | 301.41 | 283.82 | 512.16 | 115.60 | 10.00 |
Cash And Cash Equivalents End Of Year | 71.06 | 301.41 | 283.82 | 512.16 | 115.60 |